Skip to main content
Fig. 4 | Journal of Experimental & Clinical Cancer Research

Fig. 4

From: Loss of Ufl1/Ufbp1 in hepatocytes promotes liver pathological damage and carcinogenesis through activating mTOR signaling

Fig. 4

Hepatic Ufl1 or Ufbp1 deficiency leads to activation of the mTOR signaling pathway. A, B Immunostaining of p-mTOR in liver tissues extracted from 6-month-old Ufbp1Δ/Δhep, Ufbp1Δ/Δhep, and control mice (n = 5 mice/group). C, D Western blot analysis of the key molecules involved in the mTOR signaling in Ufl1Δ/Δhep, Ufbp1.Δ/Δhep, and control mice with or without 12 weeks of HFD feeding. Quantitative data are shown in the right panel. All western blots were independently repeated at least three times with consistent results. ** p < 0.01; *** p < 0.001

Back to article page